The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice
Medical Sciences · 26.06.2026 · 14 (3) · 347
DOI: 10.3390/medsci14030347 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 26.06.2026. Verfasst von Nidha Shapoo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYC Health & Hospitals/Metropolitan Hospital, New York Medical College, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Neoplasms, Endocrine System Diseases, Endocrinology, Medical Oncology. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The emergence of immune checkpoint inhibitors, targeted therapies, CAR T-cell therapy, and antibody–drug conjugates has transformed modern oncology, significantly improving survival across a wide range of malignancies. However, these advances have also introduced a growing spectrum of endocrine and metabolic complications, redefining the scope of endocrine practice. Therapy-induced endocrinopathies, including thyroid dysfunction, hypophysitis, adrenal insufficiency, diabetes, pancreatitis, dyslipidemia, gonadal dysfunction, and metabolic syndrome, are recognized as clinically significant and often long-lasting consequences of cancer treatment. Unlike classical endocrine disorders, these conditions frequently present abruptly, display atypical clinical patterns, and require complex multidisciplinary management. This review explores the evolving field of oncoendocrinology, focusing on the mechanisms, clinical manifestations, and management of endocrine toxicities associated with novel cancer therapies. We also discuss the long-term endocrine sequelae of cancer treatment and the growing need for structured survivorship care and endocrine surveillance. In addition, we discuss future directions in oncoendocrinology, including predictive biomarkers, the need for treatment standardization, integrated care models, survivorship surveillance, and precision-based approaches to endocrine care. As cancer survival continues to improve, early recognition and long-term management of endocrine complications are becoming essential to optimizing both quality of life and overall outcomes in cancer survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, NYC Health & Hospitals/Metropolitan Hospital, New York Medical College, New York, NY 10029, USA.
ORCID-Profile: Nidha Shapoo
Zitieren
APA
Shapoo, N., Boma, N., Gotlieb, V., Mattana, J., Belokovskaya, R., & Franco, A. (2026). The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice. Medical Sciences, 14(3), 347. https://doi.org/10.3390/medsci14030347
Vancouver
Shapoo N, Boma N, Gotlieb V, Mattana J, Belokovskaya R, Franco A. The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice. Medical Sciences. 2026;14(3):347. doi:10.3390/medsci14030347
BibTeX
@article{Shapoo2026,
author = {Shapoo, Nidha and Boma, Noella and Gotlieb, Vladimir and Mattana, Joseph and Belokovskaya, Regina and Franco, Alberto},
title = {The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {3},
pages = {347},
doi = {10.3390/medsci14030347}
}
EUVIMED